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Abstract The HSPA2 gene is a poorly characterized member
of the HSPA (HSP70) family. HSPA2was originally described
as testis-specific and expressed at the highest level in pachy-
tene spermatocytes of rodents, the expression of which is not
induced by heat shock. HSPA2 is crucial for male fertility.
However, recent advances have shown that HSPA2 is
expressed in various tumors and in certain types of somatic
tissues. In this review, we summarize the current knowledge
on the HSPA2 expression pattern, including information on
transcriptional, translational, posttranslational, and epigenetic
mechanisms which regulate HSPA2 expression. We also pres-
ent and discuss the current views concerning the functions of
the HSPA2 protein in spermatogenetic, somatic, and cancer
cells. The knowledge of the properties of HSPA2, although
limited, shows this protein as a unique member of the HSPA
family. However, understanding whether this protein could
become a relevant cancer biomarker or a therapeutically ap-
plicable target requires extensive further studies.
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Introduction
More than 50 years ago, studies of Ferrucio Ritossa (Ritossa
1962) paved the way for exciting research which resulted in
the discovery of a cellular reaction known as the heat shock
response. As we know now, this is a highly universal response
of almost all kinds of cells and all species exposed to factors/
conditions that could affect the normal structure of cellular
proteins. The major feature of the heat shock response is the
rapid induction or considerable stimulation of the expression
of genes encoding heat shock proteins (HSPs), the function of
which is to minimize the harmful effects of environmental or
endogenous molecular stressors (Gidalevitz et al. 2011). As a
result of long-term studies, multiple HSPs and HSP-related
proteins have been identified which are classified (mostly on
the basis of similar molecular weights and amino acid se-
quence similarity) into several families. Guidelines for the
nomenclature of the human HSPs have been recommended
by Kampinga et al. (2009), and in this review, we will follow
them.
The general function of HSPs, regarded as molecular chap-
erones, is their involvement in the maintenance of intracellular
homeostasis, primarily by controlling the process of protein
folding. Many HSPs act as molecular partners for other highly
specialized proteins such as signal transducers and transcrip-
tion factors. HSPs also exhibit anti-apoptotic properties and,
as well, can modulate various immune responses. All these
properties make HSPs of prime interest in various fields of
medicine as potential clinically useful markers or targets for
therapeutic intervention (Kakkar et al. 2014; Ciocca et al.
2013).
The largest group of heat shock proteins is the HSPA
(HSP70) family (Table 1), which in humans contains at least
13 members, only some of which are highly heat/stress induc-
ible (Kampinga et al. 2009). Within the HSPA family, there
are two genes, namely HSPA2 and HSPA1L, which were
originally identified as highly specific for spermatogenesis.
The aim of this review is to summarize the current knowledge
onHSPA2 gene expression and regulation as well as to discuss
possible functions of the gene in spermatogenic, normal so-
matic, and cancer cells.
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Cloning and structure of the HSPA2 gene
The first clue suggesting the existence of a testis-specific
hsp70-related gene was the detection in total RNA isolated
from rat testis of a highly abundant 2.7-kb transcript which
hybridized with DNA probes derived from Drosophila or
human heat-inducible hsp70 genes and with mouse genomic
DNA sequences (then unidentified) cloned into the pM1.8
plasmid (kindly given to us by Dr. Rick Morimoto)
(Krawczyk et al. 1987b). The expression pattern of the 2.7-
kb transcript during the seminiferous epithelium cycle and
postnatal testis development, and the disappearance of this
transcript from testis of rats exposed to factors which impaired
spermatogenesis with concomitant degeneration of seminifer-
ous epithelium, indicated the corresponding gene to be highly
and selectively activated in pachytene spermatocytes
(Krawczyk et al. 1987a; Krawczyk et al. 1988; Krawczyk
and Szymik 1989). The gene was isolated from a rat genomic
library, cloned, and named Hst70 (Wisniewski et al. 1990).
The current name is HSPA2 (Entrez Gene ID: 60460).
In a parallel study, Zakeri and Wolgemuth (1987) found in
the testis of adult mice a similar 2.7-kb transcript, which
hybridized with a DNA probe corresponding to the murine
heat-inducible hsp70/hsp68 gene. This transcript was abun-
dantly expressed in postmeiotic early spermatids but
was barely detectable in prophase spermatocytes. Such
an expression pattern suggested that this particular tran-
script was coded rather by a spermatid-specific gene.
This gene was characterized later and named Hsc70t (current
name; HSPA1L, Entrez Gene ID: 15482) by Matsumoto and
Fujimoto (1990).
The mouse counterpart of the rat hst70/HSPA2 gene was
identified by Zakeri et al. (1988) by screening a mouse DNA
genomic library with the above-mentioned pM1.8 plasmid as
a probe.Cloning and sequencing of the murine ortholog of the
rat hst70/HSPA2 gene (then named Hsp70-2; Entrez Gene ID:
15512) confirmed that its 5′ end fragment was present in the
pM1.8 genomic DNA clone (Zakeri et al. 1988).
The structure of the transcription unit of the rat and mouse
HSPA2 gene is similar. They have an intron within the 5′
untranslated region and two main transcription start sites (T2
and T1) located at around 116 base pairs (bp) and around 351-
bp upstream of the ATG codon (numbers related to the posi-
tion in the rat gene) respectively (Widłak et al. 1994, 1995;
Dix et al. 1996b; Scieglinska et al. 2001). Accordingly, two
variants of the HSPA2 transcripts are synthesized in mouse
and rat testis, both having a similar size (2.7 kb) but a different
structure of their 5′ end. The population which originates from
the distant T1 transcription start site undergoes splicing. The
second, non-spliced variant of messenger RNA (mRNA)
originates from the T2 start site (approx. 116-bp upstream of
ATG) placed within the intron (Scieglinska et al. 2001).
The human HSPA2 gene (Gene Entrez ID: 3306), which
has been cloned from a human placenta genomic library
(Bonnycastle et al. 1994), encodes a protein with 98.2 and
98.4 % amino acids (aa) sequence similarity to its mouse and
rat counterparts, respectively. The most conspicuous differ-
ence between the human and rodent HSPA2 protein is the
insertion of 7 aa near the carboxyl end (aa 623–629) of human
HSPA2. Transcription of the human HSPA2 gene initiates at a
single transcription start site, which corresponds to the T2 site
of the rodent ortholog gene (placed 109-bp upstream of the
Table 1 Genes belonging to the HSPA family in human genome






HSPA1A HSP70-1; HSP72; HSPA1 6p21.33 3303 641 (70,0) 83.5
HSPA1B HSP70-2b 6p21.32 3304 641 (70,0) 83.5
HSPA1L hum70t; hum70t; Hsp-hom 6p21.33 3305 641 (70,4) 82
HSPA2 Hsp70-2b, Hsp70.2 14q23.3 3306 639 (70,0) 100
HSPA5 BIP; GRP78; MIF2 9q33.3 3309 654 (71,0) 60.9
HSPA6 Heat shock 70 kD protein 6 (HSP70B′) 1q23.3 3310 643 (71,0) 78.3
HSPA7 1q23.3 3311 ND ND
HSPA8 HSC70; HSC71; HSP71; HSP73 11q24.1 3312 646 (70,9) 86.3
HSPA9 GRP75; HSPA9B; MOT; MOT2; PBP74 5q31.2 3313 679 (73,7) 46
HSPA12A FLJ13874; KIAA0417 10q25.3 259217 675 (141,0) 13.1
HSPA12B RP23-32L15.1; 2700081N06Rik 20p13 116835 686 (75,7) 14.5
HSPA13 Stch 21q11.2 6782 471 (51.9) 23.8
HSPA14 HSP70-4; HSP70L1; MGC131990 10p13 51182 509 (54,8) 28.3
ND no data
a Amino acid homology to the protein encoded by HSPA2
b Please note that in the literature, the same name was sometimes used for two different genes, e.g., HSPA1B and HSPA2
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ATG codon) (Piglowski et al. 2007). The human gene, local-
ized at 14q24.3 (Bonnycastle et al. 1994), has no intron(s) and
its expression gives rise to only one population of mRNA
molecules (Piglowski et al. 2007).
The human and rodent HSPA2 genes show the highest
amino acid sequence similarity (86.3 %) to the HSPA8 gene.
According to a recent study, in which phylogenetic trees of the
human HSPA genes have been computed based on the align-
ment of their protein products, HSPA2 together with
HSPA8 groups into one of three subgroups of one of
the seven major evolutionary-related groups of HSPA
genes. A second subgroup of this group includes
HSPA1A, HSPA1B, and HSPA1L genes while the third
one includes HSPA6 and HSPA7 genes (Brocchieri et al.
2008). Evolutionary analysis presented by Brocchieri
et al. 2008 also suggested that the sequence of
HSPA2, HSPA1, and HSPA6 genes originated from the
HSPA8 gene by retrotransposition.
Expression pattern of the HSPA2 gene in normal somatic
and pathological tissues
Although initially the HSPA2 gene was described as testis-
specific, subsequent studies revealed that it could be
expressed also in somatic tissues. The first hint which pointed
to this came from the study of transgenic (TG)mice, because a
transgene composed of a chloramphenicol acetyltransferase
(CAT) reporter gene fused to the rat HSPA2 promoter was
expressed not only in the testis, but also in the brain (Widłak
et al. 1995). The expression of the HSPA2 gene in the mouse
brain, at the highest level in the hippocampus, was subse-
quently shown by Northern blotting and in situ hybridization
(Murashov and Wolgemuth 1996b). The use of the more
sensitive RT-PCR method enabled detection of low levels of
HSPA2 mRNA present in multiple rat and mouse tissues,
except liver (Scieglińska et al. 1997; Dix et al. 1996b).
Activity of the HSPA2 promoter was also observed during
mouse embryogenesis (Murashov and Wolgemuth 1996a;
Rupik et al. 2006).
A study aimed to identify cell types which express the
HSPA2 gene was performed in TG mice bearing the transgene
composed of the rat HSPA2 promoter and an enhanced green
fluorescent protein (EGFP) reporter. Visualization of
EGFP fluorescence in TG mice tissues and detection
of endogenous HSPA2 protein (by Western blot and
immunohistochemistry) indicated that HSPA2 expression
is restricted to certain types of tissues and specific cells
(Vydra et al. 2009; Table 2).
The finding of abundant anti-sense transcript (2.8 kb) in
somatic mouse tissues, detected mainly in various brain struc-
tures (Murashov and Wolgemuth 1996a, b), suggests a high
complexity of the HSPA2 expression pattern in rodents.
However, at present, a functional meaning of this anti-sense
RNA is entirely obscure.
The first study on the expression of HSPA2 mRNA in
human tissues showed an abundant HSPA2 transcript in a
majority of somatic tissues with the exception of liver and
peripheral blood leukocytes (Bonnycastle et al. 1994;
Table 2). Subsequent studies confirmed the expression of
HSPA2 mRNA in numerous immortalized non-tumorigenic
cell lines derived from breast, bronchus, and prostate (Rohde
et al. 2005; Piglowski et al. 2007; Scieglińska et al. 2008),
although not in cell lines derived from human embryonic
kidney (Hageman et al. 2011) and normal urothelium
(Garg et al. 2010b). The search for HSPA2 protein per-
formed by immunohistochemistry using multitissue micro-
arrays and a highly specific anti-HSPA2 anti-serum re-
vealed that beside testicular cells, HSPA2 is expressed in
several tissues in a cell-type-specific manner (Scieglinska
et al. 2011; Table 2).
The bioinformatic data available in the BioGPS (www.
biogps.org) and UNIGENE (www.ncbi.nlm.nih.gov/
unigene) databases support the view that the HSPA2 gene
can be expressed in multiple, but not all, somatic tissues.
UNIGENE predicts approximate expression patterns by
assessing the relative number of expressed sequence tags
(ESTs) per tissue, while BioGPS collects data obtained
through analysis of high-density oligonucleotide arrays.
According to these databases, the highest level of HSPA2
transcripts can be found in the testis and brain of both human
and mouse. In other tissues, the mRNA is present at substan-
tially lower levels, if any (Table 2). However, the pattern of
HSPA2 gene transcription in human and mouse somatic tis-
sues is not fully overlapping, and the relative abundance of the
HSPA2mRNA is significantly higher in human than in mouse
somatic tissues (Table 2).
The expression of the HSPA2 gene, both at protein and
mRNA levels, was also demonstrated by several groups in
cancer cell lines originated from various human malignancies
as well as in primary malignant tumors (details in Table 3).
Our recent immunohistochemical study with the use of tissue
microarrays demonstrated that the HSPA2 protein is widely
expressed in human malignancies, although the percentage of
HSPA2-positive samples may vary between different tumor
histotypes (Scieglinska et al. 2014). For instance, HSPA2 was
found in a majority of skin, breast, or lung squamous cell
cancer (SCC) cases, but only in a minority of prostate and lung
adenocarcinomas (Scieglińska et al. 2008, 2014). Because
high HSPA2 expression was associated with negative prog-
nosis in esophageal SCC, non-small cell lung cancer
(NSCLC), and liver hepatocellular cancer (HCC) patients
(Zhang et al. 2013; Scieglinska et al. 2014; Fu et al. 2014),
it seems that this protein could be a clinically relevant cancer
biomarker (Table 3). We discuss the possible influence of
HSPA2 on cancer phenotype in the later section of this review
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(“Function of HSPA2 in normal somatic and cancer cells”
section).
An important issue facing HSPA researchers concerns
obtaining antibodies highly specific for a particular member
of the HSPA family. Themajor problem is cross-reactivity of a
given anti-HSPA antibody with several HSPA proteins due to
very high amino acid sequence similarity between them. This
problem pertains even to commercial, commonly used anti-
HSPA antibodies (Chow et al. 2010; Scieglinska et al. 2011).
Table 4 collects data on antibodies used for HSPA2 detection.
So far, rabbit polyclonal anti-sera raised in accordance with a
protocol developed by Rosario et al. (1992) against a short
peptide derived from the C-terminal part (aa 611–628) of
mouse HSPA2 have been the most commonly used (Son
et al. 1999; Rohde et al. 2005; Daugaard et al. 2007;
Scieglińska et al. 2008, 2011, 2014; Garg et al. 2010a, b). It
Table 2 Summary on the expression of the HSPA2 gene in selected human and mouse tissues
Human HSPA2; Gene ID: 3306 Mouse HSPA2 (Hsp70.2); Gene ID: 15512
Northern
blota
BioGPSb ESTc Proteind Cell typed BioGPSe ESTc Proteinf Cell typef
Adrenals nd 19.6 60 + Cortex—zona reticularis
cells
43.8 0 + Medulla—chromaffin cells
Bladder nd nd 0 − – 190.5 61 + Muscularis; urothelium—umbrella
cells
Lung + 230.9 17 + Bronchial epithelium 57.5 30 + Bronchial epithelium
Heart + 34.4 67 − – 20.7 0 − –
Brain ++ 2189.0 641 + Glial cells, ependymal
cells
145.4 73 + Cortex—pyramidal cells; cerebellum
—Purkinje cells; dentate gyrus—
granular and molecular layers;
hippocampus—mossy fiber;
ependyma; pia mater, choroid
plexus, subcommissural organ;
neurons in subventricular zone




18.8 nd nd nd
Kidney ++ 252.4 198 + Cortex—distal tubules 18.4 0 Parietal layer of Bowman’s capsules
Liver – 33.6 4 − – 18.0 0 − –
Ovary ++ 9.9 9.0 nd nd 89.5 0 + Oocytes from primodial and primary
follicles, follicle—granulosa cells,
ovarian mesothelium
Placenta ++ 229.0 687.6 nd nd 32.9 nd nd nd
Prostate + 51.2 21 − – 52.6 0 + Cuboidal epithelial cells
Skeletal muscle +++ 29.8 27 − – 25.0 36 nd nd
Skin nd 19.2 147 + Epidermis—basal layer nd 58 + Hair bulbs, epidermis
Small intestine ++ 185.7 nd + Epithelium—goblet cells,
paneth cells; smooth
muscle fibers of lamina
muscularis mucosae
38.6 nd + Epithelium—goblet cells; muscularis,
enteric ganglia
Spleen + nd 92 − – 13.1 10 + Peyer’s patches
Testis +++ 2276.0 553 + Spermatocytes and
spermatids
6748.9 344 + Spermatocytes and spermatids
Thyroid nd 44.6 0 − – nd 0 nd nd
a Results according to Bonnycastle et al. (1994); nd no data, + weak, ++ moderate, +++ strong hybridization signal
b Data on expression of human HSPA2 extracted from BioGPS database; expression values obtained for 211538_s_at probe set; nd no data
c Number of ESTs corresponding to the HSPA2 gene per million transcripts in the given tissue; data on relative EST number extracted from the
UNIGENE database (www.ncbi.nlm.nih.gov/unigene); nd no data
d Results of protein expression in human tissues according to Scieglinska et al. (2011); nd no data, + positive detection, − negative detection
e Data on expression of human HSPA2 extracted from the BioGPS database; expression values obtained for 1417101_at probe set; nd no data
f Results of protein expression in mouse tissues according to Vydra et al. (2009); nd no data, + positive detection, − negative detection
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is worth mentioning that, due to the presence of a glycine-rich
7 aa insertion (GGGGAGA after serine 623) in the C-terminal
part of human HSPA2, a corresponding peptide should not be
considered as an antigen for generation of anti-HSPA2 anti-
bodies. This insertion makes the C-terminal part of human
HSPA2 highly similar to other glycine-rich proteins
(Scieglinska et al. 2011).
The antigen affinity purification of the rabbit polyclonal
HSPA2 anti-serum, raised in accordance with Rosario’s
protocol, improved both the sensitivity and specificity
of detection. Such purified anti-HSPA2 antibody showed
no cross-reactivity with recombinant HSPA1, HSPA6,
and HSPA8 (the most similar to HSPA2) proteins
(Scieglińska et al. 2008, 2011). To the best of our
knowledge, no extensive verification of the specificity
of other anti-HSPA2 antibodies (Table 4), including
possible cross-reaction with other HSPA members, has
been published.
Table 3 Summary on HSPA2 expression in cancer cell lines and human primary metastatic tumors
Organ Cell lines HSPA2
expression
mRNA/protein
Tumors HSPA2 (results of IHC) Clinical significance
Bladder Cancer: HTB-1a, UMUC-3a,
HTB-9a, HTB-2a




Normal urothelial cell linea −/− Overexpression in 21 % of
tumors (n=19, TMA)i






Cervix Cancer: SiHae, CaSkie, C-33 Ae,
HeLab,c,e








Esophagus nd nd Esophageal SCC Expression in 75 % of tumors
(n=120, PS)k
Expression associated with primary
tumor, TNM stage, lymph node
metastases, and recurrencek
Expression correlated with shorter
patients OSk
Germ cell Teratocarcinoma: NTERA2f nd/+ nd nd nd
Liver Cancer: HepG2d,g −/−d +/+g Liver HCC High expression in 57 % of
tumors (n=119, PS)j
Expression related to tumor size,
differentiation, and stagej
Cancer: HUH7b +/nd Expression in 17 % of tumors
(n=18, TMA)i
High expression correlated with
shorter patients OSj
Lung Cancer: NCI-H1299d, A549d,
NCI-H358d
+/+ Lung NSCLC Expression in 62 % of tumors
(n=85, PS)i
Nuclear expression associated
with histology and TNM stagei
Non-tumorigenic: BEAC-2Bd +/+ High expression correlated with
shorter patients OSi




IHC immunohistochemistry, PS paraffin-embedded postsurgical tumor samples, TMA tissue microarray, SCC squamous cell carcinoma, AC adenocar-
cinoma, HCC hepatocellular carcinoma, NSCLC non-small cell lung carcinoma, OS overall survival, nd no data, + positive detection, − negative
detection
a Results according to Garg et al. 2010b
b Results according to Rohde et al. 2005
c Results according to Daugaard et al. 2007
d Results according to Scieglińska et al. 2008
e Results according to Garg et al. 2010a
f Results according to Sasaki et al. 2008
g Results according to Huang et al. 2009
h Results according to Alekseev et al. 2011
i Results according to Scieglinska et al. 2014
j Results according to Fu et al. 2014
k Results according to Zhang et al. 2013
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Regulation of the expression of the HSPA2 gene
DNA regulatory elements required for HSPA2 expression
in rodent testis
The HSPA2 gene, initially classified as unique, testis-specific
member of the HSPA family, was thus presumed to be under
the control of factors specific for spermatogenic cells. In order
to determine the DNA sequences required for such expression
pattern, and due to lack of suitable in vitro models, we con-
structed TG mice bearing a transgene composed of a CAT
reporter fused to various fragments of the rat HSPA2 gene
promoter. This approach allowed to establish that a relatively
short fragment of DNA (−367 to −203 nt in relation to ATG)
located directly downstream of the T1 transcription start site
(within the non-coding exon 1) is sufficient to drive testis-
enriched and developmentally regulated expression of the
transgene (Fig. 1). Within this region, we identified two short
stretches which we termed box A (nt −346 to −325) and box B
(nt −260 to −235) sharing the highest degree of nucleotide
sequence homology between the mouse and rat genes. These
boxes were shown to be of critical importance for transgene
expression in the testis of TGmice (Fig. 1; Widłak et al. 1994;
Widłak et al. 1995; Dix et al. 1996b; Scieglinska et al. 2001,
2004; Widlak et al. 2007a).
A search for potential cis-regulatory elements within the
box A region led to the identification of a consensus sequence
for binding of Sp1 transcription factor (GC-box) and a se-
quence highly similar to the octamer-binding transcription
factor 1 binding site (Oct1-like). In turn, within the box B
region, we found an estrogen-responsive element (ERE)-like
sequence which differed by one nucleotide from the ERE and
a H1t-like motif highly similar to the sequence involved in
regulation of theH1t gene expression. Downstream of the box
B region, just in front of the T2 transcription start site, a
second GC-box is placed. The localization of these regulatory
elements in the HSPA2 promoter along with the results of the
functional promoter analysis is summarized in Fig. 1.
Band shift analysis revealed that the testes of immature rats
(9–10 days old), which do not express the HSPA2 gene,
contain some protein(s) that specifically interacts with the
Oct1-like motif and the GC-boxes, respectively (Scieglińska
et al. 2004; Widlak et al. 2007a). This observation indicates
that some, so far unidentified protein(s), may act as
Table 4 Examples of antibodies used for HSPA2 detection
Host/
Clonality
Antigen Purity Source Reference
R/P M, bovine thyroglobulin-conjugated
peptide (aa 611–628)b
– Custom-made Son et al. (1999)a; Huszar et al.
(2000)a; Alekseev et al. (2009)a





Custom-made Scieglinska et al. (2008, 2011, 2014)
R/P M, ovalbumin-conjugated peptide
(aa 611–628)b
– Custom-made Rohde et al. (2005); Daugaard
et al. (2007)




Custom-made Garg et al. (2010a, b)
R/P H, ovalbumin-conjugated peptide
(aa 611–627)c
– Custom-made Huang et al. (2009)
R/P H, sperm HSPA2 excised from
preparative 2-D gels
– Custom-made Naaby-Hansen and Herr
(2010)




Redgrove et al. (2013)




Redgrove et al. (2013)
M/Mo H, full-length recombinant protein
(aa 1–639)c
Protein G purified Abcam (ab55290) Alekseev et al. (2011); Wu
et al. (2011)
R/P H, full-length HSPA2 isolated from
spermatozoa
– Custom-made Huszar et al. (2000)
M/Mo H, recombinant protein – Santa Cruz Biotech (JJ-3) Zhang et al. (2013)
G/P H, peptide mapping within internal
region of HSPA2 (aa not specified)
Affinity purified Santa Cruz Biotech (K-12) Fu et al. (2014)
H human, M mouse, G goat, Mo monoclonal, P polyclonal, R rabbit
a Anti-serum obtained by Rosario et al. 1992
bNCBI Reference Sequence NP_001002012.1
c NCBI Reference Sequence NP_068814.2
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repressor(s) of HSPA2 gene expression in spermatogonia and
early spermatocytes. Therefore, it is possible that dissociation
of these repressors from the HSPA2 promoter is a prerequisite
for activation of the gene expression in pachytene spermato-
cytes. In regard to the TE-1 and ERE-like motifs of the box B,
we found that these sequences are not involved in the regula-
tion of HSPA2 gene expression in testis (Scieglińska et al.
2004; Krawczyk et al. 1992). In summary, the available data
allow us to hypothesize that in spermatocytes, theHSPA2 gene
could be under positive control of some general transcription
factors (probably including their testis-specific variants). It is
also probable that transcriptionally competent chromatin
could be one of the main requirements for HSPA2 gene
expression. Such a supposition is partially supported by the
observation that the HSPA2 promoter is also active when
present in an episomal form both in testicular and somatic
cells (Widłak et al. 2003b; 2007a).
It is worth noting that the cis and trans elements involved in
the HSPA2 gene regulation are still poorly characterized.
However, the identification of the promoter fragment required
for testis-enriched expression enabled construction of TG
mice in which expression of various proteins, such as CAT
(Widłak et al. 1995; Scieglinska et al. 2001), EGFP (Widłak
et al. 2003b; Rupik et al. 2006), heat shock transcription factor
HSF1 (Widłak et al. 2003a; Vydra et al. 2006), heat shock
protein HSPA1 (Widlak et al. 2007c), or Cre recombinase
(Inselman et al. 2010), was effectively targeted into
spermatocytes.
Translational and posttranslational regulation of HSPA2
expression in rodent testis
Recent study has suggested that, in rodent testis, the expres-
sion of the HSPA2 gene could be regulated at the translational
and posttranslational levels by mechanisms that engage sev-
eral different proteins. Hu antigen R (HuR), an RNA-binding
protein, is known to influence the translation of multiple
mRNAs by binding to their 3′ untranslated region and (among
others) controls stability of long-lived mRNAs that are trans-
lated at late stages of spermiogenesis (Nguyen Chi et al.
2009). Aberrant expression of HuR protein (either deficiency
or overexpression) in mice testis led to defective spermato-
genesis manifested by massive death of spermatocytes (Chi
et al. 2011). It has been found that HuR supports the optimal
binding of the HSPA2 mRNA to translating ribosomes in
elongating spermatids and possibly also in pachytene sper-
matocytes (Chi et al. 2011).
HSPA2 expression in testis can be regulated at posttrans-
lational level by proteins such as the following: the multifunc-
tional Bat3 (HLA-B-associated transcript 3, also known as
BAG6) chaperone belonging to BCL2-associated athanogene
(BAG) domain protein family (Sasaki et al. 2008; Kawahara
et al. 2013); HSPA binding protein HSPBP1, a nucleotide
exchange factor of HSPA proteins and inhibitor of protein
degradation mediated by the carboxy terminus of HSP70
interacting protein CHIP (Rogon et al. 2014); and eukaryotic
translation initiation factor 4 gamma 3 (Eif4g3, Sun et al.
2010).
Bat3 and the co-chaperone HSPBP1 were shown to bind to
HSPA2 and prevent its ubiquitination and proteasomal degra-
dation in the testis (Sasaki et al. 2008; Rogon et al. 2014).
Deficiency of Bat3, or HSPBP1, in knockout (KO) mice leads
to male infertility caused by impaired spermatogenesis with
morphological features similar to those observed in HSPA2
null mice. It turned out that in the testis of these two knock-out
mice strains, the level of HSPA2 protein is significantly re-
duced (Sasaki et al. 2008; Rogon et al. 2014). Bearing in mind
that HSPA2 is expressed in certain somatic cells, it would be
important to elucidate to what extent HSPA2 expression in
non-testicular cells could be regulated by controlled degrada-
tion. Such a Bat3-dependent regulatory mechanism seems to
exist because depletion of Bat3 was associated with decreased
stability of HSPA2 in mouse embryonic fibroblasts (MEFs)
and human teratocarcinoma cells (Sasaki et al. 2008). Also,
the CHIP inhibitors HSPBP1 and BAG2 were shown to
jointly control the proteasomal degradation of HSPA2 in
MEF cells (Rogon et al. 2014).
Fig. 1 Summary of results concerning functional analysis of the activity
of the HSPA2 promoter in transgenic mice testes. The upper diagram
shows the structure of the HSPA2 transcription unit. The potential se-
quences implicated in regulation of the HSPA2 gene expression in rodent
tissues are indicated. Note that only the regulatory sequences that were
subjected to functional studies are shown. T1 (−353) and T2 (−116)
transcription start sites. The bottom diagram shows the promoter frag-
ments that were fused to a reporter gene and analyzed in transgenic mice
testes. Transgene expression (positive); No transgene expression
(negative). Activities of constructs 1 and 4 were reported in Scieglinska
et al. (2001), those of constructs 2 and 3 were described in Widlak et al.
(2007a), construct 5 was evaluated in Dix et al. (1996b), and finally,
construct 6 was assessed in Scieglińska et al. (2004). Numbers are
coordinates of DNA fragment position in relation to A (+1) in the ATG
translation start codon.DEL deletion,MUT point mutations, tk thymidine
kinase promoter
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Eif4g3, another protein which is supposed to modulate the
level of HSPA2, is a multipurpose adapter connecting mRNA
and ribosomes that acts as a scaffold protein for other factors
involved in the formation of the initiation complex. Missense
mutation in exon 36 of the mouse Eif4g3 gene causes a failure
of spermatocytes to exit meiotic prophase. Interestingly, the
HSPA2 protein is absent from spermatocytes of Eif4g3mutant
mice in spite of the presence of Bat3 and normal levels of the
HSPA2 mRNA (Sun et al. 2010). These authors hypothesized
that Eif4g3 could be engaged in the translation of some
unidentified regulator(s) of HSPA2 protein stability or be
involved in initiation of HSPA2 translation.
Regulation of the HSPA2 gene in human tissues
Mechanisms and factors that modulate the activity of the
human HSPA2 gene are even less understood than its rodent
counterparts. Functional promoter analysis revealed the 392-
nt-long DNA fragment localized directly upstream of the ATG
codon to be the shortest promoter fragment sufficient to sup-
port transcription of the CAT reporter gene both in cancer cells
expressing (A549) and non-expressing (HepG2) the endoge-
nous HSPA2 gene (Piglowski et al. 2007). These results indi-
cate that the transcription factors necessary to support the
HSPA2 promoter activity at a basal level are contained in
somatic cells irrespectively of the status of the endogenous
gene activity, allowing speculation that epigenetic mecha-
nisms could be of prime importance in the regulation of the
HSPA2 gene expression.
The accumulating evidence points to DNA methylation as
one of the most important epigenetic mechanisms modulating
the HSPA2 expression level in human cells. HSPA2 gene
methylation was detected in numerous breast, cervical, blad-
der, and renal cancer cell lines (Ye et al. 2012; Pulverer et al.
2012; Costa et al. 2010; Sova et al. 2006). Since treatment of
cells with 5-azacytidine (a DNA methylation inhibitor) re-
stored HSPA2 transcription to a high level (Ye et al. 2012;
Sova et al. 2006), but hypermethylation induced the opposite
effect (Costa et al. 2010), it seems probable that the methyl-
ation status of theHSPA2 gene correlates with its transcription
level. In genome-wide studies designed to unveil new bladder
cancer-specific epigenetic markers, the HSPA2 gene was
found among the most frequently methylated genes both in
bladder cancer cell lines and in primary bladder tumors, but
not in normal urothelial tissue (Costa et al. 2010; Reinert et al.
2011). The frequent cancer-specific hypermethylation of the
gene was also detected in endometrial and invasive cervical
cancers (Fiegl et al. 2004; Widschwendter et al. 2004).
Although the above-mentioned observations strongly sug-
gest that epigenetic modification could be important for reg-
ulation of HSPA2 gene expression, there are some controver-
sies regarding this issue. While hypermethylation-related re-
pression of the HSPA2 gene in primary bladder tumors has
been reported (Costa et al. 2010; Reinert et al. 2011), others
found the HSPA2 gene to be highly expressed in bladder
cancer cell lines and in primary urothelial tumors (Garg et al.
2010b). Similar discrepancies have emerged in the case of
HeLa (cervix) and MCF-7 (breast) cancer cell lines. Whereas
high expression of theHSPA2 gene in these cells was reported
by several groups (Rohde et al. 2005; Daugaard et al. 2007;
Garg et al. 2010a), in other works, theHSPA2 gene was found
to be hypermethylated and expressed at insignificant levels
(Sova et al. 2006; Pulverer et al. 2012; Ye Ch et al. 2012). The
reasons for these inconsistencies are unknown.
The HSPA2 gene expression in response to heat shock
and hypoxia
In somatic cells exposed to heat shock, a subset of HSP genes
is activated by binding of the HSF1 transcription factor to the
regulatory heat shock elements (HSEs) present in promoters
of stress-inducible genes. Rodent orthologs of theHSPA2 gene
contain HSE-like sequence of low similarity to the canonical
HSE and does not bind constitutively active mutant of HSF1
(Widlak et al. 2007b). The HSPA2 gene expression is not
induced by heat shock in rodent spermatogenic and somatic
cells (Krawczyk et al. 1988; Zakeri et al. 1988; Zakeri et al.
1990). Also, the human HSPA2 gene is not induced by heat
shock (Scieglińska et al. 2008; Hageman et al. 2011), and no
binding of HSF1 to theHSPA2 promoter was detected in heat-
shocked human cells (Trinklein et al. 2004; Hageman et al.
2011; Vihervaara et al. 2013). Noteworthy, up-regulation of
HSPA2 gene expression, likely mediated rather by HSF2 and
not HSF1, was observed in K562 erythroleukemia cells upon
treatment with hemin, a differentiation-inducing metabolite
(Trinklein et al. 2004).
Increasing the temperature of rat testes by placing them in
the abdominal cavity (experimental cryptorchidism) results in
rapid disappearance of the HSPA2 mRNA and degeneration
of seminiferous epithelium (Krawczyk et al. 1987a; Widlak
et al. 2007b). Similarly, a marked reduction of the HSPA2
expression level occurred in parallel with rapid degeneration
of seminiferous epithelium due to massive apoptosis of sper-
matocytes when the constitutively active mutant of HSF1 was
overexpressed in testes of transgenic mice (Nakai et al. 2000;
Widłak et al. 2003a; Vydra et al. 2006). At present, the
mechanism by which HSF1 affects HSPA2 gene expression
is unknown. HSF1 could possibly suppress some genes which
encode so far unidentified factors crucial for HSPA2 expres-
sion in testis (Widlak et al. 2007b). The detrimental influence
of HSF1 on the seminiferous epithelium demonstrates that the
response of somatic and spermatogenic cells to heat shock is
clearly different. This dissimilarity also manifests itself in the
observation that the forced overexpression of HSPA1 in sper-
matocytes of TG mice shows no protective effect against
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apoptosis induced either by experimental cryptorchidism or
by overexpression of active HSF1 (Widlak et al. 2007c).
The study of cancer cells pointed to the possible activation
of the HSPA2 expression by hypoxia, a condition frequently
associated with tumor propagation. In fact, hypoxia increased
the HSPA2 expression in human hepatoma (HepG2), breast
(MCF-7), and cervical (HeLa) cancer cells. Functional pro-
moter studies and chromatin immunoprecipitation assays con-
firmed that the activation of the HSPA2 gene was mediated by
interaction of hypoxia-inducible factor (HIF)-1 transcription
factor with the hypoxia-responsive element (HRE) localized
at 446-bp upstream of the transcription start site (Huang et al.
2009). Our recent study revealed that HSPA2 gene expression
can also be modulated by HIF-1 and hypoxia in keratinocytes,
but in contrast to HepG2 cells, both primary keratinocytes and
the immortal human keratinocyte line HaCaT respond to
hypoxia by a significant decrease in the HSPA2 gene expres-
sion level (our unpublished results). This observation seems
relevant in the context of a crucial role of HIF-1 in the
maintenance of skin homeostasis (Cho et al. 2008; Rezvani
et al. 2011). Physiological oxygen pressure in the epidermis
ranges between 0.2 and 8 %, and thus, moderate hypoxia is a
physiological condition during growth and differentiation of
keratinocytes (Rezvani et al. 2011; Evans et al. 2006).
Consequently, one can assume that HIF-1-dependent modu-
lation of HSPA2 gene expression in keratinocytes might be
related to normal processes of development/differentiation of
skin epithelium.
Function of the HSPA2 protein in spermatogenesis
Phenotype analysis of HSPA2 KO mice led to the conclusion
that the HSPA2 gene is crucial for male, but not female,
fertility (Dix et al. 1996a). HSPA2 deficiency led to severe
degeneration of seminiferous epithelium manifested by mas-
sive apoptosis of pachytene spermatocytes and lack of
postmeiotic cells (Dix et al. 1996a, 1997). Profiling the ex-
pression of molecular markers specific for defined stages of
spermatogenesis established that HSPA2 depletion severely
impaired the late stages of spermatocyte development (Dix
et al. 1997).
The HSPA2 protein was found to localize along the struc-
tures formed by synaptonemal complexes in pachytene sper-
matocytes of wild-type mice (Allen et al. 1996). Microscopic
observation of the testis of HSPA2 null mice suggested that
HSPA2 is required for desynapsis of synaptonemal complexes
(Dix et al. 1997). In HSPA2 KO males, spermatogenesis
arrested at G2/M and did not progress to the M stage of
meiosis. Subsequent analysis revealed that HSPA2 is indis-
pensably required for the formation of the cyclin-dependent
kinase 1 (CDK1)/cyclin B1 complex in spermatocytes and
confirmed its essential role for progression of meiosis. HSPA2
was found to interact with CDK1, but not with cyclin B, and
only when the kinase was not complexed with cyclin B1 (Zhu
et al. 1997).
The HSPA2-dependent regulation of CDK1/cyclin B1 ac-
tivity seems to be modulated by at least two proteins: H1t, a
testis-specific variant of linker histone H1, and tNASP, a
testis/embryo form of nuclear autoantigenic sperm protein
(Alekseev et al. 2009). The latter belongs to a family of
specific histone chaperones which facilitate the incorporation
of linker histones into chromatin and enable the progression of
the cell cycle through the G1/S border (Finn et al. 2012).
Intriguing data indicate the occurrence of interaction between
tNASP, H1t, HSPA2, and CDK1 inmouse spermatocytes. H1t
binds to the tNASP-HSPA2 complex. This interaction en-
hances weak intrinsic HSPA2 ATPase activity, increases the
ability of HSPA2 to tether CDK1, and concomitantly prevents
the binding of cyclin B1 to HSPA2/CDK1 complexes.
Altogether, the coordinated action of tNASP and histone H1t
modulates the ability of HSPA2 to form an active CDK1/
cyclin B1 complex and regulates the progression of meiosis
(Alekseev et al. 2009).
Experimental data suggest that during mouse spermiogen-
esis, HSPA2 also participates in the chromatin condensation.
At the beginning of this multistage process, both core and
linker histones are replaced by their testis-specific variants.
Concomitant, massive hyperacetylation of chromatin is be-
lieved to destabilize its nucleosomal structure and to facilitate
the replacement of testis-specific histones by transition pro-
teins (TPs) and finally by other basic DNA-packaging pro-
teins (Gaucher et al. 2010). Proteomic analysis and micro-
scopic visualization revealed that in elongating spermatids,
HSPA2 undergoes redistribution from a dispersed intranuclear
location to subacrosomal domains, and these changes corre-
lated with the cessation of histone acetylation and histone
removal (Govin et al. 2006). Detection of complexes contain-
ing TP1, TP2, and HSPA2 led to the conclusion that HSPA2
performs a role of a specific chaperone for DNA-packaging
TPs, being involved in the assembly of new spermatid-
specific nuclear structures (Govin et al. 2006).
The HSPA2-dependent replacement of histones by TP is
supposed to be modulated by poly(ADP-ribose) polymerases
PARP-1 and PARP-2. These enzymes belong to the large
PARP family, members of which contribute to the epigenetic
regulation of various physiological processes including chro-
matin reorganization during spermiogenesis (Dantzer et al.
2006; Quenet et al. 2009; Meyer-Ficca et al. 2009). Mass
spectrometry analysis revealed that in mouse spermatids,
PARP-2 interacts with HSPA2 in a TP2-dependent manner
and PARP-1 modifies HSPA2 structure by ADP-ribosylation
(Quenet et al. 2009). These results suggest that HSPA2, to-
gether with TP2, PARP-1, and PARP-2, could form
spermatid-specific complex(es), presumably of crucial
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importance for chromatin remodeling. Likely, coordinated
processes of PARP-1-dependent poly(ADP-ribosyl)ation of
HSPA2, PARP-2-dependent poly(ADP-ribosyl)ation of TP,
and chaperoning activity of HSPA2 exerted on TP2 and TP1
might contribute to chromatin reorganization and formation of
spermatozoa (Quenet et al. 2009).
There is some indirect evidence implying that the
spermatid-specific chromatin remodeling can be affected by
phospho ry l a t i on o f HSPA2 . Acco rd ing to the
PhosphoSitePlus (http://phosphosite.org) database, HSPA2
can be phosphorylated at some serine and threonine residues
in vivo. Moreover, HSPA2 was found to be among potential
targets of serine/threonine phosphoprotein phosphatase 1
gamma 2 (PPP1CC2; Henderson et al. 2011). Expression of
PPP1CC2, one of the two alternatively spliced isoforms
encoded by the Ppp1cc gene, is restricted to spermatogenic
cells. Disruption of the Ppp1cc gene results in aberrant sper-
miogenesis manifested by abnormal chromatin packing (his-
tone retention), increased germ cell apoptosis, and, conse-
quently, deficiency of condensing and elongating spermatids
(Varmuza et al. 1999; Forgione et al. 2010). Taking into
account that PPP1CC2 can directly interact with HSPA2 and
PPP1CC2 depletion leads to the accumulation of
hyperphosphorylated HSPA2 in testis, it was proposed that
the PPP1CC2-dependent modulation of HSPA2 structure/
activity could contribute to chromatin remodeling during
spermiogenesis in mouse (Henderson et al. 2011).
The above data suggest that in mice (and possibly in other
rodents), posttranslational modifications of HSPA2 could be
crucial for the process of chromatin remodeling, presumably
switching the ability of HSPA2 to interact with specific client
proteins during different stages of spermiogenetic maturation.
Such an intriguing possibility should be however experimen-
tally verified.
A number of biochemical and clinical observations show
that also in humans, expression of the HSPA2 gene is required
for male fertility. However, the results of studies published so
far suggest that the expression pattern and functions of HSPA2
in rodent and human spermatogenesis may not fully overlap.
In the human testis, HSPA2 is expressed at a significantly
higher level in elongating spermatids and spermatozoa than in
spermatocytes (Huszar et al. 2000; Motiei et al. 2013;
Redgrove et al. 2012). So far, neither the role of human
HSPA2 in the dissociation of the synaptonemal complex
nor its chaperoning activity exerted on the components
of cyclin-CDK complexes has been documented.
Instead, adequate evidence points to a crucial role of
HSPA2 in spermiogenetic maturation and sperm ability
to fertilize an oocyte.
Early studies linked the reduced levels of HSPA2 (initially
described as an unusual variant of creatinine kinase M) with
aberrant spermiogenetic maturation and production of non-
functional sperm characterized by retention of cytoplasm,
aberrant plasma membrane remodeling, and lack of zona
pellucida (ZP) binding sites (Huszar et al. 2000; Huszar
et al. 1997; Huszar et al. 1998). Low level of HSPA2 was also
correlated with increased aneuploidy frequencies in immature
sperm. The type of aneuploidy (disomies) allowed to specu-
late that low HSPA2 expression might be related to impaired
meiotic division of human spermatocytes (Kovanci et al.
2001).
In subsequent studies, reduced expression of the HSPA2
gene was found in the testes or in spermatozoa of men with
abnormal spermatogenesis (Feng et al. 2001; Cedenho et al.
2006; Lima et al. 2006; Terribas et al. 2010). In infertile men,
also a low number of HSPA2-positive sperm were detected
(Motiei et al. 2013). Recently, an association between im-
paired fertilizing ability of sperm from patients diagnosedwith
idiopathic male infertility and a total lack of HSPA2 in their
sperm has been reported (Redgrove et al. 2012).
There are discrepancies between results on HSPA2 locali-
zation in sperm. Motiei et al. (2013) have shown that sperm
maturation is associated with rearrangements of HSPA2 local-
ization from intracellular in non-capacitated sperm, to super-
ficial in capacitated spermatozoa. Other group has shown that
HSPA2 localizes solely in intracellular sperm compartments
regardless of the capacitation status (Redgrove et al. 2012;
2013). However, despite these controversies, it seems evident
that HSPA2 is important for sperm-egg recognition. Early
studies demonstrated that a reduced level of HSPA2 in sper-
matozoa is manifested by decreased ability of sperm to inter-
act with oocyte and to fertilize it (Huszar et al. 1994).
Diminished sperm HSPA2 levels were shown to predict
in vitro fertilization failure (Ergur et al. 2002). According to
recent studies performed by Redgrove et al. (2012; 2013),
HSPA2 is a component of a multimeric sperm-egg recognition
complex which contains sperm adhesionmolecule 1 (SPAM1)
and arylsulfatase A (ARSA) proteins, both previously impli-
cated in sperm-oocyte interactions. The authors proposed that
SPAM1 is positioned on the membrane of non-capacitated
sperm to mediate binding and dispersion of the hyaluronic-
rich matrix of the cumulus mass. As sperms penetrate the
cumulus mass and finish capacitation, the complex is
reoriented to express ARSA, one of the putative receptors
for the ZP. In this model, HSPA2 is localized intracellularly,
and its activity could provide a driving force for SPAM1 and
ARSA movements. Investigation of the dynamic structure of
the HSPA2/ARSA/SPAM1 complex also pointed to potential
capacitation-dependent phosphorylation of HSPA2 mediated
via activity of protein kinase A (Redgrove et al. 2013). This
further implies that posttranslational modifications of HSPA2
could have a crucial impact on its activity. Although the
results cited above point to an essential role for HSPA2
in the sperm-egg recognition process, a comprehensive
understanding of its function in the fertilization process
still requires further studies.
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Function of HSPA2 in normal somatic and cancer cells
At present, the function of HSPA2 in human somatic cells is
poorly characterized and can be only inferred from a few
studies. Two recent studies have demonstrated that HSPA2
exhibits chaperoning and cytoprotective activity. Hageman
et al. (2011) have shown that overexpression of HSPA2 in
human embryonic kidney HEK-293 cells enhanced refolding
of heat-denatured luciferase and suppressed formation of lu-
ciferase aggregates in heat-shocked cells. We have reported
that overexpression of HSPA2 in Chinese hamster lung fibro-
blasts (V79 cells) increased the resistance of cells to apoptosis
induced by heat shock or proteasome inhibitors (Filipczak
et al. 2012). Interestingly, HSPA2 did not protect cells against
toxic effects caused by the microtubule-affecting drugs vin-
blastine and paclitaxel or by the DNA-intercalating topoisom-
erase II inhibitor doxorubicin. Therefore, one can speculate
that HSPA2 has selective cytoprotective activity. HSPA2
could also influence the function/structure (but not stability)
of lysosomal/endosomal membranes. Such a supposition
emerged from the observation that extracellularly supplied
recombinant HSPA2 co-localized with markers specific for
late endosomes and lysosomes (Kirkegaard et al. 2010).
Although expression of the HSPA2 gene is not induced by
heat shock (Scieglińska et al. 2008; Hageman et al. 2011), a
sudden increase in temperature causes rapid translocation of
HSPA2 from the cytoplasm into the nuclei and nucleoli as
well as into the area of centrosomes (Scieglińska et al. 2008).
Such a pattern of HSPA2 translocation is similar to that
observed for the heat-inducible HSPA1 and HSPA6 proteins
(Pelham 1984; Hut et al. 2005; Khalouei et al. 2014). This
suggests that HSPA2 may participate in the protection of
nucleolus and/or centrosome integrity under conditions of
thermal (and possibly other) stress(es) (Scieglińska et al.
2008), as suggested earlier for HSPA1 (Pelham 1984; Hut
et al. 2005).
The majority of the knowledge on the HSPA2 function in
cancer cells has been inferred from studies in which the
expression of the HSPA2 gene was silenced by RNA interfer-
ence (RNAi) technology (Rohde et al. 2005; Daugaard et al.
2007; Garg et al. 2010a; 2010b). The earliest studies revealed
that even single transfection of HeLa or MCF-7 cells with
siRNA targeted against HSPA2mRNA induced a senescence-
like phenotype and G1 cell cycle arrest followed by apoptosis-
like cell death (Rohde et al. 2005; Daugaard et al. 2007).
Because HSPA2 depletion had no effect on proliferation of
non-cancerous immortalized epithelial cells derived from
breast or prostate epithelia, it has been concluded that
HSPA2 is specifically required for growth of cancer cells
(Rohde et al. 2005). The importance of HSPA2 for cancer cell
proliferation has been underlined by observations showing
reduced growth of human urothelial and cervical cancers cells
in response to HSPA2 depletion (Garg et al. 2010a, b).
Moreover, Garg et al. (2010a, b) reported that HSPA2 knock-
down decreased migration of cancer cells.
The results described above are in contrast with the effects
of HSPA2 depletion in non-small cell lung cancer (NSCLC)
cell lines that were obtained by our group. By stably infecting
NSCLC cells using viral vectors (lentiviruses or retroviruses)
encoding small hairpin RNAs (shRNAs), we effectively re-
duced HSPA2 gene expression by up to 90 % of the controls
(non-infected or infected with scrambled shRNA). However,
no effects on cell viability have been detected in HSPA2-
depleted cells (Scieglinska et al., unpublished). Because each
study cited above exploited a different cancer cell line and
different gene silencing strategies, it is evident that more
systematic studies are needed in order to understand the cause
of the variable effects of HSPA2 deficit on growth of cancer
cells.
One of the most intriguing issues concerning the potential
influence of HSPA2 on the phenotype of tumor cells emerges
from the comparison of the HSPA2 expression pattern in
primary tumors and in the corresponding normal tissues
(Rohde et al. 2005; Garg et al. 2010b; Scieglinska et al.
2014). In the case of certain tumors, as exemplified by breast
and bladder cancers, HSPA2 can be detected in tumor but not
in the corresponding normal tissue (Garg et al. 2010b;
Scieglinska et al. 2011, 2014). It therefore seems evident that
in these cases, the expression of the HSPA2 gene is initiated
during tumor development. On the other hand, HSPA2 ex-
pression can be detected at comparable levels both in tumor
and corresponding normal tissue as exemplified by lung squa-
mous cell cancer (SCC) tumors and normal bronchial epithe-
lium (Scieglinska et al. 2011, 2014). Thus, one can presume
that oncogenic transformation from normal bronchial epithe-
lium to SCC lung cancer is accompanied by continued ex-
pression of the HSPA2 gene (Scieglinska et al. 2011). Finally,
all of the observations above allow to propose that HSPA2
could play different roles in various types of cancer,
depending on whether this protein was expressed in
cancer precursors or its expression was acquired during
oncogenic transformation.
Another interesting aspect of the HSPA2 expression in
tumors concerns possible functional differences between this
protein and HSPA1, another member of the HSPA family.
HSPA1 is a major stress-inducible protein which is frequently
overexpressed in various tumors. A selective silencing of
either HSPA2 or HSPA1 in HeLa cells resulted in distinct
phenotypes. While HSPA2-depleted cells acquired a
senescent-like phenotype and were arrested in G1 of the cell
cycle, silencing of the HSPA1 gene resulted in G2/M arrest
and immediate entry of cells into apoptosis. Also, a global
transcriptome analysis of HeLa cells revealed strikingly dis-
tinct changes in gene expression between HSPA2- and
HSPA1-depleted cancer cells (Rohde et al. 2005; Daugaard
et al. 2007). These observations suggest that HSPA2 and
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HSPA1 exhibit substantial functional diversity and, possibly,
they can be a part of distinct functional networks and/or they
can interact with diverse arrays of client proteins.
The role of HSPA2 in rodent somatic cells is entirely
unknown. Expression of the HSPA2 gene was observed in
major developmental events occurring during mouse embryo-
genesis (Murashov andWolgemuth 1996a; Rupik et al. 2006).
Although these results would indicate an involvement of
HSPA2 in multiple processes during mouse embryogenesis,
the deletion of the HSPA2 gene from mouse genome was not
associated with reduced litter size, developmental abnormali-
ties in newborn mice, or increased perinatal mortality as
shown earlier by Dix et al. (1996a), indicating that HSPA2 is
dispensable for mouse embryo development. At present, the
cause of this apparent discrepancy is hard to explain. Since the
HSPA2 protein has been found in embryonic mouse tissues,
one can assume that the HSPA2 deficiency during develop-
ment of HSPA2 KO mice could be substituted by other struc-
turally and functionally similar protein(s).
Concluding remarks
The features of the HSPA2 gene, although it has been studied
for more than 25 years, are still poorly characterized.
Presumably, the reason is the long-lasting conviction that the
HSPA2 gene is selectively involved in sperm cell differentia-
tion, maturation, and activity. The recent studies have demon-
strated, however, that the HSPA2 gene can be expressed at a
relatively high level in selected populations of somatic cells.
These findings allow us to assume that HSPA2 may have
some, yet unidentified, functions (possibly including behav-
ioral or cognitive) that cannot be directly inferred from obser-
vations of HSPA2 KO mice. Recent studies clearly show that
the level of HSPA expression can be regulated by epigenetic
(promoter methylation) and posttranscriptional mechanisms.
The intriguing issue concerns the role of theHSPA2 gene in
human tumor cells. Although the expression of the HSPA2
gene in tumors is unquestionable, the influence of HSPA2 on
the phenotype of cancer cells has not been unequivocally
established. One of the most important issues is to determine
to what extent HSPA2 influences survival and proliferation of
cells of various cancer histotypes. So far, in numerous studies
aimed at correlating the constitutive expression of HSPA (e.g.,
HSPA1 and HSPA8) with clinical features, the possible co-
expression of the HSPA2 gene was, for obvious reasons, not
taken into consideration. Bearing in mind that these proteins
share several properties, the question concerning the similarity
of their influence on cancer cell proliferation, resistance to cell
death signaling, immunogenic properties, etc. is important. A
clear answer to this question can be critical for verification of
the potential usefulness of HSPA2, as well as other HSPA
proteins, as clinical biomarkers. So far, there are no data
concerning HSPA2 expression in tumors and tumor cells of
rats and mice. Thus, it is unknown whether rodent models
(except xenografts) would be suitable to study the role of
HSPA2 in cancerogenesis. We hope that the data summarized
in this review show clearly that HSPA2 represents an intrigu-
ing multifunctional member of the HSPA family.
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